FTC Approves Baxter $625M Claris Buy With Antitrust Fixes
The Federal Trade Commission gave its seal of approval Thursday to medical products company Baxter International Inc.'s $625 million purchase of Claris Lifesciences Ltd.'s injectables business, on the condition that Baxter...To view the full article, register now.
Already a subscriber? Click here to view full article